Overview

Title: eConsent: Better for the patient, Better for the site

Date: Thursday, December 07, 2017

Time: 02:00 PM Greenwich Mean Time

Duration: 1 hour


Register Now:

Summary

One of the critical parts to improving patient engagement in the clinical trials is improving the informed consent process. eConsent has the potential to transform the conventional informed consent approach in clinical trials in a truly patient- centric way, while enhancing the consenting process for all stakeholders involved. From reducing errors and the burden on site staff to improving the patient experience, eConsent can significantly impact a study. This webinar will explore the latest industry and regulatory developments relating to the use of eConsent in clinical trials and what sponsors and sites need to consider before they deploy this in clinical trials.

By attending this webinar you will:

  • Learn how to reduce barriers to participation for sites and patients
  • Discover the advantages to sponsors and sites in ensuring compliance with the informed consent process
  • Explore the current regulatory guidance and geographical differences
  • Examine the latest TransCelerate eConsent landscaping findings

Speakers

Caroline Forkin

Dr. Caroline Forkin
Senior Director Medical Affairs of FIRECREST
ICON

Dr. Forkin has led the interactions with regulatory authorities and ethics committees/IRBs to inform and shape the development and roll-out of FIRECREST eConsent, since 2015. In this role, she has also commissioned research into the appropriate content and approach for conveying patient-appropriate information through a multi-media format for use in the consent process. Dr. Forkin is an active member of the ACRO Transcelerate eConsent working group.

Dr. Forkin has twenty two years’ experience as a physician, primarily in infectious diseases, including nine years in Mozambique working for the World Bank and Irish Aid in International Health. Prior to ICON, she held positions in the biotech pharmaceutical industry with Shire Pharmaceuticals and Amgen Pharmaceuticals in Ireland. She holds a Membership of the Royal College of Physicians of Ireland (MRCPI), an MBA in Healthcare Management, and Diplomas in Public Health and Pharmaceutical Medicine.